Galectin-3
Resource Center
/ Recent Posts /
Galectin-3 and Apheresis: The Future of Medicine
In this webinar, Dr. Eliaz presents groundbreaking research findings and practice-tested protocols to effectively manage Galectin-3, including the use of selective apheresis showing breakthrough results ...
A 30-Year Investigation Into Culprit Biomarker Galectin-3: From Survival to Sepsis—and Beyond
For more than 30 years, Isaac Eliaz, MD, MS, LAc, has investigated Galectin-3 and its role in inflammation, fibrosis, cancer, kidney injury, sepsis, and emerging ...
Why Do Some Respond Better to GLP-1 Drugs? Galectin-3 May Offer a Clue
Why do two patients with similar metabolic profiles sometimes respond so differently to the same GLP-1 medication? Galectin-3 may offer an important clue. This emerging ...
Demystifying Endotoxins: Identifying and Quenching the Fire Within
Join functional medicine pioneer Dr. Tom O’Bryan, DC, CCN, DACBN, CIFM, as he shares breakthrough research, clinical strategies, and functional medicine frameworks to understand, diagnose, ...
A New Understanding of Endotoxin Trafficking and Chronic Inflammation
Arguably, the most prominent ‘sleeper’ disease that contributes to 1 in every 2 to 3 hospital deaths is sepsis.1 Fueled by lipopolysaccharide (LPS)2— referred to ...
Galectin-3 and MCP: Brain Health, Cognitive Function and Beyond
Galectin-3 is emerging as a key biomarker and driver of inflammation, fibrosis and chronic disease. This review examines the clinical relevance of galectin-3 and the ...
Preventing Cancer Progression and Metastasis: The Role of Modified Citrus Pectin in Targeting Galectin-3
MCP has demonstrated significant anticancer activity in vitro, in animal studies, and in clinical studies. Beyond its anticancer properties, MCP is shown to improve metal ...
Galectin-3: Culprit Biomarker of Inflammation, Fibrosis & Chronic Disease – A Clinicians Guide
Galectin-3 is increasingly recognized as a culprit biomarker and primary driver of inflammation, fibrosis, and chronic disease. Knowing how to test for and address this ...
Blocking Galectin-3: A Powerful Strategy for Neurodegeneration and Chronic Disease
Over the last decade or so, research interest in the pro-inflammatory and pro-fibrotic immune protein galectin-3 (Gal-3) has skyrocketed. Today, thousands of published scientific papers—including ...
Blocking Galectin-3 for Health and Longevity
In this video, Josh Helman, MD discusses the pathogenic mechanisms of the pro-inflammatory immune protein galectin-3 and its role in neurodegenerative diseases, biofilm formation, autoimmunity ...
